Download presentation
Presentation is loading. Please wait.
1
Fig. 1. Serum levels of IGF-I vs
Fig. 1. Serum levels of IGF-I vs. weeks of treatment during dose titration in men and women. From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11): doi: /jcem J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society
2
Fig. 2. Serum levels of IGFBP-3 vs
Fig. 2. Serum levels of IGFBP-3 vs. weeks of treatment during dose titration in men and women. From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11): doi: /jcem J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society
3
Fig. 3. Serum levels of ALS vs
Fig. 3. Serum levels of ALS vs. weeks of treatment during dose titration in men and women. From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11): doi: /jcem J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society
4
Fig. 4. Waist-to-hip ratio vs
Fig. 4. Waist-to-hip ratio vs. months of treatment with rhGH in men and women. From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11): doi: /jcem J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society
5
Fig. 5. AGHDA score vs. months of treatment with rhGH in men and women.
From: Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults J Clin Endocrinol Metab. 1998;83(11): doi: /jcem J Clin Endocrinol Metab | Copyright © 1998 by The Endocrine Society
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.